对于脏疾病的CRISPR-Cas系统的进展
Bhupendra Puri1, Yogesh A Kulkarni2, Anil Bhanudas Gaikwad1
1Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, India.
Progress in molecular biology and translational science
|January 17, 2025
概括
克里斯普尔-卡斯基因编辑为治疗多囊病和急性损伤等病提供了新的方法. 这项技术精确地针对遗传原因,为各种脏疾病提供了更好的结果.
科学领域:
- 遗传学和分子生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物技术是生物技术.
背景情况:
- 病包括一系列疾病,包括急性损伤 (AKI),慢性病 (CKD),糖尿病病 (DKD),狼性炎 (LN) 和多囊性病 (PKD).
- 目前的治疗方法往往控制症状,而不是解决潜在的遗传原因.
- 克里斯普尔-卡斯技术已经成为一种强大的基因操纵工具.
研究的目的:
- 审查病研究和治疗的CRISPR-Cas系统的最新进展.
- 探索CRISPR-Cas技术在治疗单一性和复杂性脏疾病方面的潜力.
- 突出CRISPR-Cas在脏疾病中准DNA和非编码RNA的多功能性.
主要方法:
- 关于CRISPR-Cas在病学中的应用的最新科学文献的综述.
- 分析CRISPR-Cas技术在各种病模型中的基因编辑潜力.
- 检查CRISPR-Cas能力超越DNA编辑,包括非编码RNA修改.
主要成果:
- 克里斯普尔-卡斯技术可用于PKD和阿尔波特综合征等单基因脏疾病的精确基因修饰.
- 通过编辑致病突变,CRISPR-Cas显示出治疗AKI,CKD和DKD的前景.
- 该技术可以适应量身定制的疗法和编辑与脏疾病相关的非编码RNA (lncRNA,miRNA).
结论:
- 克里斯普尔-卡斯技术代表了一项重大进步,在病管理方面具有变革性的潜力.
- 针对遗传机制的个性化和精确的治疗策略可以改善患者的治疗结果.
- 交付效率的挑战和非目标效应需要进一步的研究和开发.
更多相关视频
08:14Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
12.1K
10:21Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
13.1K
相关概念视频
01:59CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
02:53CRISPR and crRNAs
16.6K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.6K
02:31Homologous Recombination
50.1K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.1K
00:49What is Genetic Engineering?
73.5K
Overview
73.5K